Advertisement
Home »

Tumour necrosis factor (TNF) antagonist therapy for paediatric inflammatory bowel disease: A systematic review.

Mar 27, 2023

ABOUT THE EXPERTS

  • Paula Martín-García

    Servicio de Medicina Preventiva y Gestión de Calidad, Hospital General Universitario Gregorio Marañón, Madrid, España. Electronic address: pau.mgar@gmail.com.

    Adolfo Alonso-Arroyo

    Departamento de Historia de la Ciencia y Documentación, Universidad de Valencia, Valencia, España.

    Ferrán Catalá-López

    Escuela Nacional de Sanidad, Instituto de Salud Carlos III, Madrid, España; Universidad de Valencia/Instituto de Investigación Sanitaria INCLIVA y CIBERSAM, Valencia, España; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Otawa, Ontario, Canadá.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement